Cambiar Aggressive Value ETF

CAMX · ETF

$35.09−$0.4028 (−1.13%)TodayMarket closed · Oct 23, 8:00 PM ET

Prev close $35.49

Latest news

NewsSep 9, 10:26 AM ETAnusuya Lahiri
From Burritos to Bulk Groceries: Uber Scales Delivery Reach with ShopRite Partner
NewsSep 2, 9:38 AM ETAnusuya Lahiri
Uber Axes 3,300 Jobs to Build Its Autonomous Future
NewsApr 20, 9:51 AM ETLekha Gupta
Honeywell Dumps Productivity Unit In $1.4 Billion Deal With Brady
NewsMay 15, 8:01 AM ETLekha Gupta
Uber, iFood Unite In Brazil To Offer One-Stop App Convenience
NewsOct 1, 8:45 AM ETLekha Gupta
CME Group Expands Nikkei Futures Offerings, Boosts Japanese Equity Derivatives
Press releaseJul 15, 1:48 AM ETPRNewswire
Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

From Burritos to Bulk Groceries: Uber Scales Delivery Reach with ShopRite Partner

Uber Axes 3,300 Jobs to Build Its Autonomous Future

Honeywell Dumps Productivity Unit In $1.4 Billion Deal With Brady

Uber, iFood Unite In Brazil To Offer One-Stop App Convenience

CME Group Expands Nikkei Futures Offerings, Boosts Japanese Equity Derivatives

Camurus announces positive Phase 3 results from the ACROINNOVA 2 study of octreotide SC depot (CAM2029) in acromegaly patients